Clinical Trials Browser

Nasopharyngeal Carcinoma, Mesothelioma, Malignant, Adenocarcinoma, Mucinous, Adenoma, Islet Cell, Nasopharyngeal Neoplasms, Carcinoma, Merkel Cell, Carcinoma, Neuroendocrine

NCT04276376 2025-12-01

ARIANES

Phase 2 Terminated

130 enrolled

Other solid neoplasm

Solid Tumor

NCT04996017 2025-03-13

AtezoMeso

Phase 3 Recruiting

162 enrolled

Other solid neoplasmThoracic

Mesothelioma, Malignant, Mesothelioma

NCT06003621 2024-11-15

MoST-TAP

Phase 2 Recruiting

96 enrolled

Other solid neoplasm

Solid Tumor, Adult

NCT04185831 2024-08-22

MEGALiT

Phase 2 Active not recruiting

167 enrolled

Other solid neoplasm

Solid Tumor

NCT04480372 2024-07-01

SAKK 17/18 (ORIGIN) MPM & NSCLC >1st Line Gemci & Atezo Ph II

Phase 2 Completed

68 enrolled

Other solid neoplasmThoracic

Mesothelioma, Malignant, Carcinoma, Non-Small-Cell Lung

NCT02478099 2024-05-03

MPDL3280A-treatment-IST-UMCG

Phase 2 Active not recruiting

81 enrolled

Other solid neoplasm

Locally Advanced or Metastatic Solid Tumors

NCT05809336 2023-04-12

Gut Microbial Metabolites Inosine Combined With PD-1/PD-L1 Inhibitor for Patients With Malignant Advanced Solid Tumors

Phase 2/3 Completed

172 enrolled

Other solid neoplasm

Advanced Solid Tumor

NCT03654833 2023-03-14

MiST

Phase 2 Unknown

186 enrolled

Other solid neoplasmThoracic

Mesothelioma, Malignant

NCT05429866 2023-03-08

Immunological Variables Associated to ICI Toxicity in Cancer Patients

Phase 2 Unknown

441 enrolled

BreastDermatologicGastrointestinalGenitourinaryHead & NeckOther solid neoplasmThoracic

Mesothelioma, Malignant, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Gastrointestinal Neoplasms, Head and Neck Neoplasms, Carcinoma, Hepatocellular, Melanoma, Carcinoma, Merkel Cell, Small Cell Lung Carcinoma

NCT03786419 2021-05-13

A Study of Atezolizumab in Unresectable or Advaced Malignant Pleural Mesothelioma

Phase 2 Withdrawn

Other solid neoplasmThoracic

Mesothelioma, Malignant, Thoracic Neoplasms

Clinical Trials

Atezolizumab and Bevacizumab in Treating Patients With Rare Solid Tumors

ARIANES

AtezoMeso

MoST-TAP

MEGALiT

SAKK 17/18 (ORIGIN) MPM & NSCLC >1st Line Gemci & Atezo Ph II

MPDL3280A-treatment-IST-UMCG

Gut Microbial Metabolites Inosine Combined With PD-1/PD-L1 Inhibitor for Patients With Malignant Advanced Solid Tumors

MiST

Immunological Variables Associated to ICI Toxicity in Cancer Patients

A Study of Atezolizumab in Unresectable or Advaced Malignant Pleural Mesothelioma